Vector Science and Therapeutics Corp. Announces Collaboration and SAFE Investment in Whoopi Wellness, Inc.

Investment advances collaboration on peptide-based products for women's wellness

MEQUON, Wis., Oct. 13, 2026 /PRNewswire/ -- Vector Science and Therapeutics Corp. (TSXV: PAIN) ("Vector" or the "Company") today announced that it has entered into a strategic relationship with Whoopi Wellness, Inc. ("Whoopi Wellness"), a subsidiary of WhoopFam LLC and co-founded by Whoopi Goldberg.

Vector has made an investment in Whoopi Wellness through a Simple Agreement for Future Equity (SAFE). The companies plan to work together on peptide-based products for women's wellness using peptides formulated and manufactured by Vector. Vector only uses peptides that have been tested using validated analytical testing to ensure purity, potency, endotoxin levels and sterility. Whoopi Wellness is committed to high-quality, safe, rigorously tested peptides in its products.

Strategic Rationale

Vector believes this relationship brings together Vector's peptide manufacturing expertise and Whoopi Wellness's consumer brand to develop products for women's wellness.

Vector's proprietary delivery technology is central to the relationship. The Company's intellectual property portfolio includes 15 pending patent applications covering multi-route peptide and biologic delivery, lyophilized peptide formulations with point-of-care reconstitution, and advanced transdermal delivery. Peptides are typically unstable once in liquid form, which has limited how they can be used in consumer products. Vector's expertise is in the novel delivery of molecules in multiple forms while preserving the integrity of the molecule. In the Whoopi Wellness products, Vector will be using its IP and formulation knowledge to deliver products with peptides that retain their potency and that are shelf stable in liquid and gel formats. Vector believes this capability positions the companies to explore peptide-based products in formats suited to Whoopi Wellness's personal care and wellness portfolio.

"This relationship gives Vector early exposure to a company working in an area adjacent to our own. Women's health and the use of peptides are important areas of innovation, and our proposed exclusive arrangement with Whoopi Wellness will help build awareness of Vector's approach to the best quality and safety," said Bill Jackson, Chief Executive Officer of Vector Science and Therapeutics. "We look forward to helping bring Whoopi Wellness products to market and supporting the company's mission to improve women's wellness."

"Taking care of ourselves and the people we love is at the heart of Whoopi Wellness," said Whoopi Goldberg, Co-Founder. "We're creating products for real people and real lives, with quality, care and trust behind everything we do. Working with Vector brings science and innovation into that vision, and I'm excited about what we can create together."

"Our customers trust us to be thoughtful about what goes into every product we make," said Davina Kaonohi, Co-Founder, Whoopi Wellness. "Vector's commitment to rigorous testing and manufacturing quality made them the right partner as we explore peptide-based products for women's wellness. This investment reflects shared confidence in where we're headed together."

About Vector Science and Therapeutics Corp.

Vector Science and Therapeutics Corp. (TSXV: PAIN) is a medical technology company advancing drug delivery technology and pharma-grade peptide manufacturing for the sports medicine, regenerative medicine, and pain management markets. Vector's peptides are pharma-grade, not research-grade: they are manufactured under cGMP, FDA, and ISO-compliant conditions, Rx-labeled, and sold directly to physicians for physician use, rather than distributed through the research-only channels associated with research-grade material. The Company's product and intellectual property portfolio is focused on advanced transdermal delivery, precision catheter systems, localized pain management, pancreatic oncology, and smart wound care. Vector is headquartered in Mequon, Wisconsin. For more information, visit https://vectorscience.co/.

About Whoopi Wellness, Inc.

Whoopi Wellness, Inc. is a consumer health and lifestyle company, a subsidiary of WhoopFam LLC and co-founded by Whoopi Goldberg, bringing her voice, cultural relevance and lifelong commitment to well-being into a growing portfolio of intimate care, personal care, beauty and wellness products. Built on a legacy of care, comfort and wisdom, the company is creating thoughtful, high-quality products designed to support real bodies and real lives at every stage. With a vision that spans generations, Whoopi Wellness is building a trusted platform rooted in honesty, inclusivity and care.

 Cautionary Note Regarding Forward-Looking Information

This news release contains "forward-looking information" within the meaning of applicable Canadian securities legislation. Forward-looking information includes, but is not limited to, statements regarding the proposed exclusive arrangement between the parties, the development and commercialization of peptide-based products, and the anticipated benefits of the relationship described in this release. Forward-looking information is based on management's current expectations and assumptions and is subject to known and unknown risks, uncertainties, and other factors that may cause actual results to differ materially from those expressed or implied, including the risk that the parties do not finalize a definitive exclusive arrangement, that the SAFE does not convert into equity, or that anticipated products are not successfully developed or commercialized. Readers are cautioned not to place undue reliance on forward-looking information. The Company does not undertake any obligation to update forward-looking information except as required by applicable securities laws.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

SOURCE Vector Sciences & Therapeutics